Exposing fraud is no feel-good exercise but worth it for the sake of science

+News

SUMMER HIATUS

Exposing fraud is no feel-good exercise but worth it for the sake of science

Thursday 27 December 2018, 12:00 AM

Osteoporosis treatments were reported as positive, but have been unmasked as fraud

We are on our summer break and the editorial office is closed until 14 January. We hope you enjoy this article which is part of Summer Hiatus, an eclectic mix from our archives throughout the year, The Conversation and other publications we share content with. Please note the comment function has been turned off while we are away. Happy reading

The Japanese researchers led others to follow false leads, absorbed funding, and exposed patients to ineffective treatments Virginia McMillan ta, Andrew Grey, Andrew Grey helps uncover fraud in medical publishing

Research

University of Auckland

Neurology

Endocrinology

Older People

Geriatric Medicine

References

1.Bolland MJ, Avenell A, Gamble GD et al. Systematic review and statistical analysis of the integrity of 33 randomized controlled trials. Neurology 2016;87:2391–2402.

2.Cockayne S, Adamson J, Lanham-New S, et al. Vitamin K and the prevention of fractures: systematic review and meta-analysis of randomised controlled trials. Arch Intern Med 2006;166(12):1256-1261.

3. Grey A, Avenell A, Bolland M. Revised Meta-analysis of vitamin K and fractures. JAMA Internal Medicine (formerly Arch Intern Med) 2018;178,8:1135.

News archive

How to Treat

+How to treat

Polypharmacy

For older people and frail people, the long-term benefit of medicines reduces and the potential for harm from adverse effects increases. When the benefit–risk balance changes in this way, medicine review and optimisation are important to simplify the therapeutic regimen, reduce inappropriate medicines and minimise risks. In this article, pharmacist prescriber Linda Bryant uses two case studies to illustrate important considerations during medicine reviews

Wednesday 28 May 2025, 12:50 AM